Brexit: Medicine Supplies Face ‘Significant Disruption’ At Ports
Situation Worst In First Quarter Of 2021
As negotiators struggle to reach agreement on the future UK/EU relationship, pharma firms have been warned to expect major hold-ups next year for medicines crossing the Channel.
You may also be interested in...
In its latest letter to medicines and medical product companies, the UK's Department of Health and Social Care says the biggest potential cause of disruption to supplies could be failure to prepare for border controls implemented by the EU member states after the end of the Brexit transition period.
New checks due to be imposed when the UK leaves the EU single market and customs union in 2021 are expected to cause widespread disruption to consignments of medicines and other vital goods at the Channel ports. The government says it has secured space on nine new ferry routes in an effort to help keep supplies going.
With time running out on the UK-EU trade deal negotiations, the UK life sciences industry looks at the fine print of the new guidance on medicines regulation and explains why a mutual recognition agreement is urgently needed.